Eupraxia Pharmaceuticals Inc.
EPRXF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $132,988 | $70,250 | $41,408 | $45,770 |
| - Cash | $25,504 | $24,736 | $20,892 | $150 |
| + Debt | $13,782 | $10,546 | $9,556 | $12,769 |
| Enterprise Value | $121,266 | $56,060 | $30,072 | $58,389 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$210 | -$193 | -$112 | -$117 |
| % Margin | – | – | – | – |
| EBITDA | -$37,395 | -$22,441 | -$20,761 | -$1,789 |
| % Margin | – | – | – | – |
| Net Income | -$38,089 | -$23,259 | -$22,990 | -$3,997 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.58 | -1.21 | -1.61 | -0.31 |
| % Growth | -30.6% | 24.8% | -419.4% | – |
| Operating Cash Flow | -$27,916 | -$18,776 | -$14,642 | -$404 |
| Capital Expenditures | -$99 | -$308 | -$432 | $0 |
| Free Cash Flow | -$28,015 | -$19,085 | -$15,073 | -$404 |